Sign in

CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company

C4 Therapeutics, Inc.

Sign in to watch
Ticker
CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475617627
Phone
(617) 231-0700
Business address
490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 4 Grant or award Director acquired 3,662 shares (grant or award)
  4. 4 Grant or award Director acquired 4,618 shares (grant or award)
  5. 8-K Event Regulation FD disclosure · Other events
  6. 4 Shares withheld for taxes Chief Financial Officer gave up 2,775 shares (to pay taxes)
  7. 144 Insider Sale of Securities
  8. 144 Insider Sale of Securities
  9. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. 144 Insider Sale of Securities
  13. 144 Insider Sale of Securities
  14. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  15. 10-Q Report Quarterly Report
  16. 8-K Event Results of operations
  17. SCHEDULE 13G Stake Statement of Beneficial Ownership
  18. 4 Shares withheld for taxes Chief Medical Officer gave up 7,397 shares (to pay taxes)
  19. 4 Grant or award Director acquired 2,650 shares (grant or award)
  20. 4 Grant or award Director acquired 3,341 shares (grant or award)

Page 1 of 28 · 548 filings